| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF01073654 |
| P8608 | Fatcat ID | release_pa3sdop2qbbt5e74r6wxuhulzu |
| P698 | PubMed publication ID | 4040567 |
| P50 | author | Charles L Litterst | Q111700731 |
| P2093 | author name string | R L Dedrick | |
| F G King | |||
| F F Farris | |||
| P2860 | cites work | Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent | Q28248838 |
| Cisplatin (cis-diamminedichloroplatinum II) | Q39798603 | ||
| cis-Diamminedichloroplatinum (II): A Metal Complex with Significant Anticancer Activity | Q39805147 | ||
| Platinate toxicity: past, present, and prospects | Q39898914 | ||
| Scaling of renal functions in mammals | Q40341781 | ||
| Blood flow and heat transfer in Walker 256 mammary carcinoma | Q40588398 | ||
| Protein sulphydryl depression during adjuvant arthritis | Q41330277 | ||
| Pharmacokinetic study of cis-dichlorodiammineplatinum(II) (DDP) in the beagle dog: thermodynamic and kinetic behavior of DDP in a biologic millieu | Q41442133 | ||
| Effect of a forced diuresis on the distribution and excretion (via urine and bile) of 195mplatinum when given as 195mplatinum cis-dichlorodiammineplatinum(II) | Q41729997 | ||
| Mechanism of cis-platinum nephrotoxicity: II. Morphologic observations | Q42470085 | ||
| Levels of sulfhydryls and sulfhydryl-containing enzymes in brain, liver and testis of manganese treated rats | Q45253783 | ||
| Blood clearance of three radioactively labelled platinum complexes: cis-dichlorodiammine platinum II, cis, trans-dichlorodihydroxy-bis-(isopropylamine) platinum IV, and cis-dichloro-bis-cyclopropylamine platinum II, in patients with malignant diseas | Q51609240 | ||
| Bone Marrow Sulphydryl Levels | Q58978704 | ||
| The effect of castration on the rate of tissue protein synthesis in vivo | Q66949562 | ||
| Kinetics of cis-dichlorodiammineplatinum | Q67467904 | ||
| Analysis of platinum in biological materials by flameless atomic absorption spectrophotometry | Q67684183 | ||
| Clinical and pharmacological studies with cis-diamminedichloroplatinum (II) | Q69025482 | ||
| Transport and Binding of Methotrexate In Vivo | Q69539183 | ||
| Nonprotein sulfhydryl alterations in F-344 rats following acute methyl chloride inhalation | Q70277910 | ||
| Role of renal cortical sulfhydryl groups in development of mercury-induced renal toxicity | Q70566451 | ||
| Methotrexate Pharmacokinetics | Q70620597 | ||
| Preparation and metabolism of a cisplatin/serum protein complex | Q70649611 | ||
| Subcellular localization of cis-dichlorodiammineplatinum(II) in rat kidney and liver | Q70653749 | ||
| Mechanism of cis-platinum nephrotoxicity: I. Effects of sulfhydryl groups in rat kidneys | Q70659289 | ||
| Alterations in the toxicity of cis-dichlorodiammineplatinum-II and in tissue localization of platinum as a function of NaCl concentration in the vehicle of administration | Q70668742 | ||
| Comparison of the iv and ip routes of administration of cisplatin in dogs | Q70669134 | ||
| Pharmacokinetics of cisplatin regional hepatic infusions | Q70678046 | ||
| Alterations in hepatic and renal levels of glutathione and activities of glutathione S-transferase from rats treated with cis-dichlorodiammineplatinum-II | Q70678316 | ||
| Changes in renal handling of platinum in cisplatinum-treated rats following induction of metabolic acidosis or alkalosis | Q70679086 | ||
| Hepatic and renal nonprotein sulfhydryl concentration following toxic doses of hexachloro-1,3-butadiene in the rat: the effect of Aroclor 1254, phenobarbitone, or SKF 525A treatment | Q70709470 | ||
| Cisplatin metabolites: a method for their separation and for measurement of their renal clearance in vivo | Q71228708 | ||
| A comparative study of the distribution in the male rat of platinum-labelled cis-dichlorodiammine platinum (II), cis-trans-dichlorodihydroxy-bis-(isopropylamine) platinum (I), and cis-dichloro-bis-cyclopropylamine platinum (II) | Q71228883 | ||
| Dynamic state of glutathione in blood plasma | Q71364194 | ||
| Assessment of cisplatin reactivity with peptides and proteins using reverse-phase high-performance liquid chromatography and flameless atomic absorption spectroscopy | Q71840419 | ||
| The mechanism of renal clearance of cisplatin (cis-dichlorodiammine platinum ii) and its modification by furosemide and probenecid | Q71840512 | ||
| Pharmacokinetics of liposome encapsulated cisplatin in rats | Q71841564 | ||
| Intraperitoneal cisplatin with systemic thiosulfate protection | Q71842628 | ||
| Pharmacokinetic modeling of cisplatin disposition in children and adolescents with cancer | Q71845073 | ||
| Protein synthesis in liver and small intestine in protein deprivation and diabetes | Q72646283 | ||
| Complexes of serum albumin and cis-dichlorodiammineplatinum (II). The role of cysteine 34 as a nucleophilic entering group and evidence for reaction between bound platinum and a second macromolecule | Q72698362 | ||
| Effect of probenecid and N′-methylnicotinamide on renal handling of cis-dichlorodiammineplatinum-II in rats | Q72784497 | ||
| Adaptation of the rat to a low-protein diet: the effect of a reduced protein intake on the pattern of incorporation of L-[14C] lysine | Q72811905 | ||
| Elimination of I131 labelled homologous and heterologous serum proteins from blood of various species | Q74428027 | ||
| The metabolism of serum proteins. I. The turnover rates of rat serum proteins | Q77147447 | ||
| P433 | issue | 1 | |
| P921 | main subject | pharmacokinetics | Q323936 |
| P304 | page(s) | 13-39 | |
| P577 | publication date | 1985-02-01 | |
| P1433 | published in | Journal of Pharmacokinetics and Pharmacodynamics | Q15766045 |
| P1476 | title | Physiological model for the pharmacokinetics of cis-dichlorodiammineplatinum (II) (DDP) in the tumored rat. | |
| P478 | volume | 13 |
| Q73088488 | Alteration of pharmacokinetics and nephrotoxicity of cisplatin by alginates |
| Q43802770 | Clinical pharmacokinetics of 3-day continuous infusion cisplatin and daily bolus 5-fluorouracil |
| Q73485184 | Effect of buthionine sulphoximine, glutathione and methimazole on the renal disposition of cisplatin and on cisplatin-induced nephrotoxicity in rats: pharmacokinetic-toxicodynamic analysis |
| Q44858924 | Effect of hyperthermia on cisplatin (CDDP) disposition to isolated perfused skin |
| Q44865752 | Effect of tumor presence on cisplatin and carboplatin: disposition in the isolated, perfused tumor and skin flap |
| Q73163251 | Effects of disopyramide and verapamil on renal disposition and nephrotoxicity of cisplatin in rats |
| Q47183780 | Molecular-weight-dependent pharmacokinetics and cytotoxic properties of cisplatin complexes prepared with chondroitin sulfate A and C. |
| Q71955829 | Organ-specific biotransformation of ormaplatin in the Fischer 344 rat |
| Q33377016 | Phase I clinical and pharmacokinetic study of zeniplatin, a new platinum complex |
| Q68642203 | Physiological modeling of drug and metabolite: disposition of oxazepam and oxazepam glucuronides in the recirculating perfused mouse liver preparation |
| Q69595374 | Physiological pharmacokinetic modeling of cis-dichlorodiammineplatinum(II) (DDP) in several species |
| Q68128779 | Physiological pharmacokinetic parameters for cis-dichlorodiammineplatinum(II) (DDP) in the mouse |
| Q40649272 | Relation between Intracellular Accumulation and Cytotoxic Activity of cis-[((1R,2R)-1,2-Cyclohexanediamine-N,N')bis(myristato)]platinum(II) Suspended in Lipiodol |
Search more.